Ian Pritchard

Ian Pritchard is an experienced leader in the healthcare and pharmaceutical sectors, currently serving as Chief Executive at Alternative Futures Group since January 2018, where previously held the position of Director of Corporate & Commercial Development and acted as Chief Executive for six months. Prior to this role, Ian held the title of Head of Proposition Development at Nuffield Health, focusing on the commercialization of health and wellbeing propositions. Ian's extensive background includes key positions such as Principal Consultant at Health Schematix Ltd, Head of Healthcare Services Development at Celesio Group (UK), and various leadership roles in project management and innovation at Lloyds Pharmacy, Quintiles, Apollo Medical Software Solutions Ltd, Innovex, and Eli Lilly. Ian's academic accomplishments include a PhD in Microbial Genetics from Liverpool John Moores University, complemented by a BSc (Hons) in Applied Biochemistry from the same institution.